| Product Code: ETC6750013 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Parkinsons Disease Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 China Parkinsons Disease Market - Industry Life Cycle |
3.4 China Parkinsons Disease Market - Porter's Five Forces |
3.5 China Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 China Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 China Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 China Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 China Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 China Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing geriatric population in China |
4.2.2 Rising awareness about Parkinson's disease and its treatment options |
4.2.3 Growing healthcare infrastructure and access to medical facilities in China |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease medications and treatments |
4.3.2 Limited availability of specialized healthcare professionals for Parkinson's disease management in China |
5 China Parkinsons Disease Market Trends |
6 China Parkinsons Disease Market, By Types |
6.1 China Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 China Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 China Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 China Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 China Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 China Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 China Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 China Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 China Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 China Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 China Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 China Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 China Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 China Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 China Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 China Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 China Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 China Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 China Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 China Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 China Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 China Parkinsons Disease Market Import-Export Trade Statistics |
7.1 China Parkinsons Disease Market Export to Major Countries |
7.2 China Parkinsons Disease Market Imports from Major Countries |
8 China Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of Parkinson's disease diagnosis in China |
8.2 Number of Parkinson's disease support groups and advocacy organizations in China |
8.3 Percentage of Parkinson's disease patients receiving timely and appropriate treatment in China |
9 China Parkinsons Disease Market - Opportunity Assessment |
9.1 China Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 China Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 China Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 China Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 China Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 China Parkinsons Disease Market - Competitive Landscape |
10.1 China Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 China Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here